{
  "zip": "102-0083",
  "sector": "Healthcare",
  "fullTimeEmployees": 184,
  "longBusinessSummary": "Sosei Group Corporation discovers, develops, and commercializes biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of AZD4635, an adenosine A2a antagonist, which is in Phase II clinical trial for the treatment of solid tumors and metastatic castration resistant prostate cancer; HTL0016878, a muscarinic M4 agonist, which is in Phase I clinical trial for the treatment of Alzheimer's disease; and dual muscarinic M1/M4 agonist, which is in pre-clinical stage for the treatment of Alzheimer's disease. It also develops HTL0014242, a mGlu5 small molecule negative-allosteric modulator, which is in Phase I clinical trial for the treatment of certain neurological order; SSTR agonist, a novel somatostatin peptide agonist, which is in Phase I clinical trial for the treatment of endocrine disorders; HTL0022562, a calcitonin gene related peptide antagonist, which is in pre-clinical stage for the treatment of migraine and other severe headaches; GLP-1 antagonist, a potent glucagon-like peptide-1 antagonist, which is in pre-clinical stage for the treatment of severe hypoglycaemia in rare diseases; and GLP-2 agonist, a potent glucagon-like peptide-2 agonist, which is in pre-clinical stage for the treatment of intestinal disorders. In addition, the company's pipeline products include OX-1 antagonist to treat cocaine-use disorders; Apelin agonist for pulmonary arterial hypertension; GPR35 agonist to treat inflammatory bowel disease; H4 antagonist and PAR2 mAb for atopic dermatitis. Sosei Group Corporation has a strategic collaboration with Kymab, PeptiDream Inc., Pfizer, MorphoSys, Genentech, Takeda Pharmaceutical Company Limited, and Captor Therapeutics SA. The company was founded in 1990 and is headquartered in Tokyo, Japan.",
  "city": "Tokyo",
  "phone": "81 3 5210 3290",
  "country": "Japan",
  "companyOfficers": [],
  "website": "http://soseiheptares.com",
  "maxAge": 1,
  "address1": "PMO Hanzomon",
  "fax": "81 3 5210 3291",
  "industry": "Biotechnology",
  "address2": "11th Floor 2-1 Kojimachi Chiyoda-ku",
  "previousClose": 16.29,
  "regularMarketOpen": 16.27,
  "twoHundredDayAverage": 14.207102,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 16.29,
  "navPrice": null,
  "averageDailyVolume10Day": 375,
  "totalAssets": null,
  "regularMarketPreviousClose": 16.29,
  "fiftyDayAverage": 15.830303,
  "trailingAnnualDividendRate": null,
  "open": 16.27,
  "averageVolume10days": 375,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": 1427414400,
  "beta": 1.269152,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 16.29,
  "priceHint": 2,
  "currency": "USD",
  "regularMarketVolume": 3000,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 1510570240,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 68,
  "priceToSalesTrailing12Months": null,
  "dayLow": 16.29,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 3000,
  "fiftyTwoWeekHigh": 18.73,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 11.16,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 16.29,
  "exchange": "PNK",
  "shortName": "SOSEI GROUP CORP",
  "longName": "Sosei Group Corporation",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "SOLTF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_1266465",
  "uuid": "048cbcb1-47e0-32ef-9c97-8a81e1521064",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": -0.26113,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 80585504,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 5.43,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.24344999,
  "netIncomeToCommon": null,
  "trailingEps": -0.665,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 3.0000002,
  "heldPercentInsiders": 0.11929,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 64137206,
  "enterpriseValue": 1312738048,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1364342400,
  "lastSplitFactor": "100:1",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": -0.554,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 16.27,
  "logo_url": "https://logo.clearbit.com/soseiheptares.com"
}